Address: Serbia Milutina milankovica 9b 11070 Belgrade ,Serbia
Tel: +381 11 22 22 700
Web: http://www.novonordisk.com/
Novo Nordisk Company was established in 1923, then under the name of Nordisk Insulinlaboratorium. Novo Nordisk Company’s offices in Belgrade started working in June of 1990, and in 2006, this subsidiary transformed in to a Serbian company – Novo Nordisk Pharma d.o.o. From the beginning of its existence in Serbia, Novo Nordisk Company offered great contribution to improvement of quality of its diabetology protection in Serbia and in reorganization of services with application of contemporary diagnostic and therapy procedures. Aside from promotional activities in endocrinology and treatment of haemophilia, and registration of medications, this organization also has a department for clinical testing of new medications in endocrinology and treatment of haemophilia. Novo Nordisk, with head offices in Denmark, employs around 30,000 people in the world and sells its products in 179 countries. Novo Nordisk employs 38 people in Serbia.
drugs
Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the country today. The separate entity Novo Nordisk d.o.o was founded in…
Milica Glisic, with over 15 years of experience in the pharma business and ten years at Wörwag Pharma, discusses the strong workforce in the Balkans, Wörwag Pharma’s mission in the…
Siniša D. Vučinić, the brains behind Aqualab Plus Systems, which holds laboratories across Serbia that offer a variety of sophisticated blood tests specifically targeted at the elderly, pregnant women and…
Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into…
Sanja Ivanic, director general of the French-Serbian Chamber of Commerce, discusses the advantages of working in Serbia, the opportunities that the country offers, Serbia’s entrance into the EU, the Chamber’s…
Vera Nikolic-Dimic, executive director of the American Chamber of Commerce (AmCham) in Serbia, pinpoints the key facets of the Serbian economy that have captivated the interests of American businesses, the…
Bojan Trkulja, managing director of INOVIA, Serbia’s innovative drug manufacturers association, underlines the importance of cooperation not only between his members but also between all the key stakeholders of the…
Rather than Mr. Bugarin’s personal views, the following information contains general statements provided by the Serbian Chamber of Commerce Current trends in pharmaceutical industry The production of the medicines in…
Priorities and plans of the Ministry of Health If we entered an election year with a major reform plan, we would not succeed in putting such proposals into parliamentary procedure.…
Roche is one of the oldest multinational pharmaceutical companies here in Serbia. How do you think your history in the country gives you an advantage today as a company? We…
Pfizer is increasingly interested in emerging markets, with a focus very much on Latin America and Asia. Given this, why is Serbia exciting for Pfizer today? Serbia is interesting for…
Serbia has had an undoubtedly troubled history since the breakup of Yugoslavia in the early 1990s. A costly war and ensuing UN sanctions have left the country’s economy a few…
As the 7th largest pharma MNC worldwide, AstraZeneca is a company that needs no introduction. However, our readers would love to hear more about your operations here in Serbia… Therefore,…
See our Cookie Privacy Policy Here
